Hegen Li
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Cancer-related molecular mechanisms research
Papers in
-
- Ubiquitin and proteasome pathways 4
- Extracellular vesicles in disease 3
-
- Lung Cancer Treatments and Mutations 7
- Ferroptosis and cancer prognosis 3
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- Jianhui Tian (13 shared papers)Yi Jiang (8 shared papers)Jiaxiang Liu (6 shared papers)Wei Huang (2 shared papers)Deyue Yan (2 shared papers)Zujun Que (7 shared papers)Zhu-Jun Mao (3 shared papers)Lingshuang Liu (5 shared papers)
In The Last Decade
Hegen Li
40 papers receiving 667 citations
Peers
Comparison fields: 5 of 80
- Biomaterials 93
- Cancer Research 80
- Oncology 141
- Complementary and alternative medicine 35
- Pharmacology 31
Countries citing papers authored by Hegen Li
This map shows the geographic impact of Hegen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hegen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hegen Li more than expected).
Fields of papers citing papers by Hegen Li
This network shows the impact of papers produced by Hegen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hegen Li. The network helps show where Hegen Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hegen Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 118 | |
| 2 | 2015 | 70 | |
| 3 | 2017 | 57 | |
| 4 | 2012 | 34 | |
| 5 | 2021 | 32 | |
| 6 | 2020 | 28 | |
| 7 | 2014 | 26 | |
| 8 | 2019 | 26 | |
| 9 | 2021 | 24 | |
| 10 | 2019 | 23 | |
| 11 | 2017 | 23 | |
| 12 | 2018 | 17 | |
| 13 | 2023 | 17 | |
| 14 | 2019 | 16 | |
| 15 | 2024 | 14 | |
| 16 | 2021 | 14 | |
| 17 | 2001 | 13 | |
| 18 | 2022 | 12 | |
| 19 | 2020 | 12 | |
| 20 | 2024 | 12 |
About Hegen Li
Hegen Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Biomedical Engineering, having authored 47 papers that have together received 684 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Nanoplatforms for cancer theranostics (7 papers), Ubiquitin and proteasome pathways (4 papers), Ferroptosis and cancer prognosis (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Extracellular vesicles in disease (3 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Biomaterials (93 citations), Cancer Research (80 citations), Oncology (141 citations), Complementary and alternative medicine (35 citations) and Pharmacology (31 citations). Hegen Li has collaborated with scholars based in China, Norway and Germany. Frequent co-authors include Jianhui Tian, Yi Jiang, Jiaxiang Liu, Wei Huang, Deyue Yan, Zujun Que, Zhu-Jun Mao, Lingshuang Liu, Zhanxia Zhang and Mo Sun. Their work appears in journals such as Materials & Design, Journal of Integrative Medicine, Journal of Ethnopharmacology, BMC Complementary and Alternative Medicine and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.